Suppr超能文献

全球孕妇淋病奈瑟菌感染的患病率:系统评价和荟萃分析。

Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis.

机构信息

Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Department of Biostatistics and Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, Iran.

出版信息

Clin Microbiol Infect. 2023 Jan;29(1):22-31. doi: 10.1016/j.cmi.2022.08.008. Epub 2022 Aug 23.

Abstract

BACKGROUND

Neisseria gonorrhoeae infection (gonorrhoea) is associated with several pregnancy complications, including preterm labour, spontaneous abortion, stillbirth, miscarriage, growth retardation, and intrauterine death.

OBJECTIVES

We performed a systematic review and meta-analysis to estimate the global and regional prevalence of gonorrhoea in pregnant women as a scientific basis for further studies.

DATA SOURCES

We systematically searched PubMed/MEDLINE, Web of Science, Embase, Scopus, and SciELO databases from inception to 10 July 2022.

STUDY ELIGIBILITY CRITERIA

We included cross-sectional, cohort, and case-control studies that reported the prevalence of gonorrhoea in pregnant women. In addition, we included baseline data for randomized controlled trials.

PARTICIPANTS

Pregnant women who were tested for gonorrhoea.

METHODS

Pooled prevalence estimates at 95% CIs were calculated using a random-effects meta-analysis model. We stratified countries according to WHO-defined regions and socio-economic factors. Moreover, sub-group-, meta-regression, and sensitivity analyses were conducted to investigate the effects of pre-determined factors on prevalence estimates and heterogeneity.

RESULTS

We identified 235 studies (249 datasets) on 19 104 175 pregnant women from 71 countries. The worldwide pooled prevalence of gonorrhoea in pregnant women was estimated at 1.85% (95% CI 1.73-1.97%), with the highest rate in the African region (3.53%) (2.84-4.29%) and the lowest rate in the European region (0.52%) (0.27-0.84%). Overall, the prevalence estimates were high among low-income countries (3.03%), pregnant women with HIV (2.81%), and pregnant women <20 years old (8.06%). A significant decreasing trend in prevalence was observed over time (β = -0.0008, 95% CI -0.0012 to -0.0004, p 0.001).

DISCUSSION

Our findings indicate that a substantial number of pregnant women have been infected with gonorrhoea globally, which calls for immediate public health measures to reduce the potential risk of infection. The study highlights the inadequacy or lack of data for many countries, emphasizing the need to expand systematic data collection efforts at national and regional levels.

摘要

背景

淋病奈瑟菌感染(淋病)与多种妊娠并发症有关,包括早产、自然流产、死产、流产、生长迟缓以及宫内死亡。

目的

我们进行了系统评价和荟萃分析,以估计全球和区域孕妇淋病的流行率,为进一步研究提供科学依据。

数据来源

我们系统地检索了 PubMed/MEDLINE、Web of Science、Embase、Scopus 和 SciELO 数据库,检索时间截至 2022 年 7 月 10 日。

研究入选标准

纳入了报告孕妇淋病流行率的横断面研究、队列研究和病例对照研究。此外,还纳入了随机对照试验的基线数据。

研究对象

接受淋病检测的孕妇。

方法

使用随机效应荟萃分析模型计算 95%CI 置信区间的汇总流行率估计值。我们根据世界卫生组织(WHO)定义的区域和社会经济因素对国家进行分层。此外,还进行了亚组分析、Meta 回归分析和敏感性分析,以调查预先确定的因素对流行率估计值和异质性的影响。

结果

我们从 71 个国家的 19104175 名孕妇中确定了 235 项研究(249 个数据集)。全球孕妇淋病的汇总流行率估计为 1.85%(95%CI 1.73-1.97%),其中非洲区域最高(3.53%)(2.84-4.29%),欧洲区域最低(0.52%)(0.27-0.84%)。总体而言,低收入国家(3.03%)、HIV 感染孕妇(2.81%)和 20 岁以下孕妇(8.06%)的流行率估计值较高。随着时间的推移,流行率呈显著下降趋势(β=-0.0008,95%CI-0.0012 至-0.0004,p<0.001)。

讨论

我们的研究结果表明,全球有相当数量的孕妇感染了淋病,这呼吁立即采取公共卫生措施来降低感染的潜在风险。研究结果突出表明,许多国家的数据不足或缺乏数据,这强调了需要在国家和区域层面扩大系统的数据收集工作。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验